Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Beam Therapeutics Inc (NASDAQ: BEAM) was $27.50 for the day, down -1.57% from the previous closing price of $27.94. In other words, the price has decreased by -$1.57 from its previous closing price. On the day, 0.82 million shares were traded. BEAM stock price reached its highest trading level at $28.91 during the session, while it also had its lowest trading level at $27.15.
Ratios:
Our analysis of BEAM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.69 and its Current Ratio is at 5.69. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on November 06, 2024, Upgraded its rating to Outperform and sets its target price to $39 from $27 previously.
On July 23, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $80.H.C. Wainwright initiated its Buy rating on July 23, 2024, with a $80 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 06 ’24 when Ciaramella Giuseppe sold 51,110 shares for $26.36 per share. The transaction valued at 1,347,050 led to the insider holds 109,150 shares of the business.
Ciaramella Giuseppe sold 51,110 shares of BEAM for $1,342,752 on Oct 14 ’24. The President now owns 160,260 shares after completing the transaction at $26.27 per share. On Oct 14 ’24, another insider, Giuseppe Ciaramella, who serves as the Officer of the company, bought 102,220 shares for $24.65 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 2313588736 and an Enterprise Value of 1425095168. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.51 while its Price-to-Book (P/B) ratio in mrq is 2.87. Its current Enterprise Value per Revenue stands at 4.076 whereas that against EBITDA is -8.861.
Stock Price History:
Over the past 52 weeks, BEAM has reached a high of $49.50, while it has fallen to a 52-week low of $18.85. The 50-Day Moving Average of the stock is 12.50%, while the 200-Day Moving Average is calculated to be 2.56%.
Shares Statistics:
BEAM traded an average of 903.81K shares per day over the past three months and 1411110 shares per day over the past ten days. A total of 81.63M shares are outstanding, with a floating share count of 72.00M. Insiders hold about 13.05% of the company’s shares, while institutions hold 81.73% stake in the company. Shares short for BEAM as of 1730332800 were 12314053 with a Short Ratio of 13.62, compared to 1727654400 on 11356434. Therefore, it implies a Short% of Shares Outstanding of 12314053 and a Short% of Float of 19.450001.
